Finance Case: What First Aid Beauty Teaches Us About the Delicate Balance Between Investors and Control
Case Summary
Background: Lilli Gordon is the founder and CEO of First Aid Beauty (FAB for short). She was previously an executive at the skincare company Fresh and sold that company to LVMH. Her own skin is sensitive, so she decided to create "a skincare brand that provides first aid for sensitive skin," positioned as "affordable but effective premium skincare."
Growth: After FAB was founded in 2009, it quickly got into Sephora (the US premium cosmetics chain) and QVC (a TV shopping channel). First-year revenue was US$2.7 million; by 2014 it had reached US$16.3 million, with US$24.8 million projected for 2015
Funding: At the start it relied on US$1 million put in by herself and friends; later came several small funding rounds and a bank credit line (US$2 million in 2015)
Challenge: In 2012 growth slowed, and Sephora warned that the brand had to grow faster or be pulled from shelves. She sold her house, self-funded and poured money into advertising, and in 2014 sales doubled.
Now: By 2015 FAB was profitable, but cash flow was tight and it had to raise its bank credit line every year. She held 47% of the shares, and at this point two PE (private equity) firms offered term sheets:
Firm A: US$85 million valuation, investing US$25.5 million (buying 30% of the shares, common stock). The money would mainly be used to buy out existing shareholders. Pros: strong expertise and a good team fit; cons: a lower valuation and more equity given up.
Firm B: US$100 million valuation, investing US$20 million (buying 20% of the shares, preferred stock). Pros: higher valuation and looser terms; cons: preferred-stock provisions and an overbearing operating partner.
Class Notes
When a company needs outside money, how do you choose between "money" and "control"?
- Where the story starts: growth eats cash
FAB was founded in 2008, positioned as "a first-aid kit for sensitive skin." With the combination of Sephora (the anchor retail channel) + QVC (the TV conversion channel), the brand leapt within just a few years from annual sales of a few million to a projected US$24.8 million in 2015.
But rapid growth comes with an iron law:
accounts receivable and inventory pile up fast,
and every year you have to go to the bank to raise your revolving Line of Credit — by 2015 it had already climbed to US$2 million.
Growth is, at heart, a black hole for cash.
Growth eats cash!
This is a lesson for Arcus42 too: we have to treat cash flow and working capital as core management metrics.
Keep a constant eye on cash flow.
- Enter the investors: Firm A vs Firm B
By 2015, founder Lilli Gordon was facing two term sheets:
Firm A
Valuation: $85M
Investment: $25.5M (30% common stock)
Cash-out: the founder could take $14.8M
Control: consent-rights threshold ≥15%, shares are common stock
Firm B
Valuation: $100M
Investment: $20M (20% preferred stock, 1x liquidation preference)
Cash-out: the founder could take $12M
Control: holding any shares at all carries consent rights; any sale/IPO/restructuring within five years requires both parties' agreement
B looks better (higher valuation, less dilution), but its terms are stricter.
Core Tensions:
A → more dilution, but looser terms;
B → less dilution, but tighter restrictions.
- The subtle clauses of control
Compare the two firms' Investor Consent Rights:
Firm A original text:
"Any material change in the Company's Core Business … (Core Business = skincare, haircare, beauty products)"
→ Core business is defined narrowly, and consent rights only kick in with a stake of ≥15%.
Firm B original text:
"Any material change … (Core Business = skincare, haircare, beauty products including beauty supplements)"
→ Core business is defined more broadly, any stake at all carries consent rights, and even an IPO/restructuring within five years needs both parties' agreement.
What this shows: control isn't your percentage of the equity — it's the contract terms.
Is FAB short of money?
It isn't short of day-to-day profit, but it relies on the bank raising its credit every year, and its cash flow is a roller coaster.
- My takeaways
Growth is a cash black hole: you have to work out ΔNWC (the increase in net working capital) ahead of time, so growth doesn't eat up all your cash.
Debt for turnover, equity as insurance: day-to-day working capital should come from bank lines or supply-chain finance; equity financing is more about gaining "long-term partners + a safety cushion for the founder."
Look at control along two dimensions: don't just look at your shareholding percentage — also look at the threshold clauses, the definition of core business, and restrictions on a sale.
Agree on governance with investors: independent directors, consent-rights thresholds and the triggers for converting preferred into common should all be written into the agreement up front.
Founder insurance matters: the founder's family cash flow can't be stretched too thin, or it will undermine a long-term mindset.
Equity financing isn't simply "trading shares for money"; it's an art of "governance by contract."
Valuation, dilution and terms intertwine to decide who really has their hands on the company's steering wheel.
Control ≠ equity percentage; control = equity + terms.
That's all — I hope it offers some inspiration as you think about "bringing in capital versus keeping control."